Clinical Trials Logo

Filter by:
NCT ID: NCT02939105 Completed - Body Fat Disorder Clinical Trials

CoolSculpting Treatment in the Upper Arms

ARM
Start date: December 2, 2016
Phase: N/A
Study type: Interventional

Evaluate the safety and efficacy of the ZELTIQ CoolSculpting System using specialized vacuum applicators for non-invasive subcutaneous fat reduction of the upper arms.

NCT ID: NCT02938429 Completed - Heart Defects Clinical Trials

Physical Activity Measured Through Accelerometers and Its Association With Endothelial Function in Young Patients With Fontan Physiology

Start date: October 2016
Phase: N/A
Study type: Interventional

This study will be a cross sectional assessment of physical activity as measured through accelerometers and its association with endothelial function of children with Fontan circulation and healthy age and gender matched controls who are followed at the University of Alberta - Stollery Children's hospital.

NCT ID: NCT02938104 Completed - Lung Cancer Clinical Trials

Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery

Start date: August 2014
Phase: N/A
Study type: Interventional

The investigators propose a randomized controlled study in patients undergoing lung resection for cancer to compare the impact of multimodal intervention composed of exercise, nutritional supplement and psychological well-being on functional exercise capacity. One group (rehabilitation group) will receive the multimodal intervention after surgery for 8 weeks; the other will start 4 weeks before surgery and continue for 8 weeks postop (prehabilitation group). In this case, both groups will be exposed to the program, which will be available to both groups postoperatively. One of the two groups will start this program 4 weeks before surgery and continue for 8 weeks postoperatively, and the other will start once they leave the hospital and continue for 8 weeks postoperatively.

NCT ID: NCT02937740 Completed - Hypogonadism Clinical Trials

Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natestoâ„¢

MyT
Start date: October 2016
Phase: Phase 4
Study type: Interventional

Multicenter study consisting of two study periods as follows: a 90-day Treatment Period, with potential extension by 30 days for those patients requiring a dose increase, as determined by the treating physician. Participants receiving 122.5mg of NATESTO (5.5 mg of testosterone) per nostril twice daily may have an increased daily dose adjustment on Day 90, based on their hypogonadism symptoms.

NCT ID: NCT02937701 Completed - Clinical trials for Arthritis, Rheumatoid

Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab

Start date: October 10, 2016
Phase: Phase 3
Study type: Interventional

The main purpose of the study was to compare rheumatoid arthritis symptom improvement in participants who were given ABP 710 to those who were given infliximab, 22 weeks after starting treatment.

NCT ID: NCT02936635 Completed - Clinical trials for Amyotrophic Lateral Sclerosis (ALS)

A Study for Patients Who Completed VITALITY-ALS (CY 4031)

VIGOR-ALS
Start date: October 17, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the long-term safety and tolerability of tirasemtiv in patients with ALS who had completed the double-blind placebo-controlled study of tirasemtiv in ALS (CY 4031).

NCT ID: NCT02935699 Completed - Acute Urticaria Clinical Trials

Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria

Start date: March 1, 2017
Phase: Phase 3
Study type: Interventional

This is a multicenter, parallel group, randomized, double-blind, active controlled, Phase III clinical study of cetirizine injection, 10 mg/mL, compared to diphenhydramine injection, 50 mg/mL (Benadryl or generic equivalent) with acute urticaria requiring treatment.

NCT ID: NCT02935634 Completed - Clinical trials for Advanced Gastric Cancer

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

FRACTION-GC
Start date: November 29, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the preliminary efficacy, safety, and tolerability of Nivolumab in combination with Ipilimumab or other treatment therapies in participants with advanced gastric cancer.

NCT ID: NCT02935582 Completed - Psoriasis Vulgaris Clinical Trials

PSOREAL - Managing PSOriasis in the REAL World

PSOREAL
Start date: January 2017
Phase:
Study type: Observational

Multinational real-life study of current psoriasis treatment strategies, topical treatment patterns and treatment outcomes of these treatments, including the newly introduced calcipotriol/betamethasone dipropionate aerosol foam fixed combination product Enstilar® (calcipotriol/betamethasone dipropionate).

NCT ID: NCT02935088 Completed - Clinical trials for Coronary Artery Disease

PRESSUREwire Study

Start date: October 12, 2016
Phase:
Study type: Observational

The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.